Literature DB >> 34926083

Atypical Giant Suprasellar Prolactinoma Presenting With Visual Field Changes in the Absence of Symptoms of Hyperprolactinemia.

Scott Sun1, Jun Q Mo2, Michael L Levy3, John Crawford4.   

Abstract

Prolactinomas are benign tumors that make up the majority of all pituitary adenoma cases and present most commonly in women. Prolactinomas presenting in adolescents and children, however, are extremely rare. We report a case of a 17-year-old male who presented with a six-month history of headaches and a previously unrecognized visual field deficit on examination. Neuroimaging revealed a large suprasellar tumor with imaging, more characteristic of a craniopharyngioma or suprasellar low-grade glioma impinging, on the left intracranial optic nerve causing right-sided hemianopsia. Due to the extensive mass effect and bitemporal hemianopsia on examination, the decision to proceed with initial surgical debulking was made following informed consent. A subtotal resection was performed where the pathology was consistent with a prolactinoma that correlated with markedly elevated prolactin (PRL) levels obtained pre and post-operatively that have not resulted until five days post procedure. The patient was subsequently treated with dopamine agonist (DA) cabergoline therapy and is now five-years disease-free with normal neurological examination and no residual tumor on neuroimaging. DA therapy has shown high clinical efficacy and should be considered prior to any surgical intervention; however, extensive mass effect may appropriate surgical debulking to increase therapy efficacy. Our case highlights an atypical appearance of a giant prolactinoma that may mimic other more common suprasellar tumors, a presentation associated with unrecognized visual field deficits, and the importance of rapid turnaround testing for serum PRL that may aid in the upfront diagnosis and management of prolactinomas.
Copyright © 2021, Sun et al.

Entities:  

Keywords:  atypical neuroimaging; pituitary adenoma; prolactinoma; suprasellar tumor; visual field

Year:  2021        PMID: 34926083      PMCID: PMC8673687          DOI: 10.7759/cureus.19632

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  11 in total

Review 1.  Pituitary tumors in children and adolescents.

Authors:  A R Lafferty; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1999-12       Impact factor: 5.958

Review 2.  Clinical practice. Prolactinomas.

Authors:  Anne Klibanski
Journal:  N Engl J Med       Date:  2010-04-01       Impact factor: 91.245

3.  Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas.

Authors:  Felipe F Casanueva; Mark E Molitch; Janet A Schlechte; Roger Abs; Vivien Bonert; Marcello D Bronstein; Thierry Brue; Paolo Cappabianca; Annamaria Colao; Rudolf Fahlbusch; Hugo Fideleff; Moshe Hadani; Paul Kelly; David Kleinberg; Edward Laws; Josef Marek; Maurice Scanlon; Luis G Sobrinho; John A H Wass; Andrea Giustina
Journal:  Clin Endocrinol (Oxf)       Date:  2006-08       Impact factor: 3.478

Review 4.  Management of cystic prolactinomas: a review.

Authors:  Afif Nakhleh; Naim Shehadeh; Irit Hochberg; Moshe Zloczower; Sagit Zolotov; Riad Taher; Deeb Daoud Naccache
Journal:  Pituitary       Date:  2018-08       Impact factor: 4.107

5.  The epidemiology of prolactinomas.

Authors:  Antonio Ciccarelli; Adrian F Daly; Albert Beckers
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

6.  Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis.

Authors:  Anika Hoffmann; Sarah Adelmann; Kristin Lohle; Alexander Claviez; Hermann L Müller
Journal:  Eur J Pediatr       Date:  2017-11-22       Impact factor: 3.183

7.  Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients.

Authors:  Sylvie Salenave; Deborah Ancelle; Thibaut Bahougne; Gérald Raverot; Peter Kamenický; Jérôme Bouligand; Anne Guiochon-Mantel; Agnès Linglart; Pierre-François Souchon; Marc Nicolino; Jacques Young; Françoise Borson-Chazot; Brigitte Delemer; Philippe Chanson
Journal:  J Clin Endocrinol Metab       Date:  2014-12-22       Impact factor: 5.958

Review 8.  Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline.

Authors:  Shlomo Melmed; Felipe F Casanueva; Andrew R Hoffman; David L Kleinberg; Victor M Montori; Janet A Schlechte; John A H Wass
Journal:  J Clin Endocrinol Metab       Date:  2011-02       Impact factor: 5.958

9.  Prolactinomas in children and adolescents. Clinical presentation and long-term follow-up.

Authors:  A Colao; S Loche; M Cappa; A Di Sarno; M L Landi; F Sarnacchiaro; G Facciolli; G Lombardi
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

Review 10.  The Role of Surgery in the Management of Prolactinomas.

Authors:  Daniel A Donoho; Edward R Laws
Journal:  Neurosurg Clin N Am       Date:  2019-07-02       Impact factor: 2.509

View more
  1 in total

1.  Resolution of Visual Field Defect in Macroprolactinoma After Treatment With Cabergoline.

Authors:  Kimitaka Shibue; Momoko Yamakawa; Namiko Nishida; Akihiro Hamasaki
Journal:  Cureus       Date:  2022-05-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.